It’s also strange indeed that Biotron favoured the HIV trial analysis first over the Covid analysis. One would think a few extra months won’t worry HiV, but Covid, (and antivirals in general) are immediate, in fact 4 years late yet people still think the Covid results are what’s going to save the company.
BIT Price at posting:
3.8¢ Sentiment: None Disclosure: Not Held
